These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 31739360)
1. Clinical Tolerance of In-Neonatal Intensive Care Unit Administration of Rotavirus Vaccine. Briggs-Steinberg C; Aboudi D; Hodson G; Shah S Am J Perinatol; 2021 Apr; 38(5):456-462. PubMed ID: 31739360 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units. Thrall S; Doll MK; Nhan C; Gonzales M; Perreault T; Lamer P; Quach C Vaccine; 2015 Sep; 33(39):5095-102. PubMed ID: 26296493 [TBL] [Abstract][Full Text] [Related]
3. Safety of rotavirus vaccine in the NICU. Monk HM; Motsney AJ; Wade KC Pediatrics; 2014 Jun; 133(6):e1555-60. PubMed ID: 24843056 [TBL] [Abstract][Full Text] [Related]
4. Rationale for In-Neonatal Intensive Care Unit Administration of Live, Attenuated Rotavirus Vaccination. Briggs-Steinberg C; Shah S Am J Perinatol; 2018 Dec; 35(14):1443-1448. PubMed ID: 29883980 [TBL] [Abstract][Full Text] [Related]
5. Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule. Saleh E; Eichner B; Clark DW; Gagliano ME; Troutman JM; Harrington L; McNeal M; Clements D J Pediatric Infect Dis Soc; 2018 Feb; 7(1):82-85. PubMed ID: 28340179 [TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa. Levin MJ; Lindsey JC; Kaplan SS; Schimana W; Lawrence J; McNeal MM; Bwakura-Dangarembizi M; Ogwu A; Mpabalwani EM; Sato P; Siberry G; Nelson M; Hille D; Weinberg GA; Weinberg A AIDS; 2017 Jan; 31(1):49-59. PubMed ID: 27662551 [TBL] [Abstract][Full Text] [Related]
7. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants. Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027 [TBL] [Abstract][Full Text] [Related]
8. Rotavirus shedding in premature infants following first immunization. Smith CK; McNeal MM; Meyer NR; Haase S; Dekker CL Vaccine; 2011 Oct; 29(45):8141-6. PubMed ID: 21856359 [TBL] [Abstract][Full Text] [Related]
9. Pentavalent rotavirus vaccine in infants with surgical gastrointestinal disease. McGrath EJ; Thomas R; Duggan C; Asmar BI J Pediatr Gastroenterol Nutr; 2014 Jul; 59(1):44-8. PubMed ID: 24614127 [TBL] [Abstract][Full Text] [Related]
10. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281 [TBL] [Abstract][Full Text] [Related]
11. Timely immunisation of premature infants against rotavirus in the neonatal intensive care unit. Ladhani SN; Ramsay ME Arch Dis Child Fetal Neonatal Ed; 2014 Nov; 99(6):F445-7. PubMed ID: 25053636 [No Abstract] [Full Text] [Related]
12. Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen). Dennehy PH; Vesikari T; Matson DO; Itzler RF; Dallas MJ; Goveia MG; DiNubile MJ; Heaton PM; Ciarlet M Hum Vaccin; 2011 May; 7(5):563-8. PubMed ID: 21441783 [TBL] [Abstract][Full Text] [Related]
13. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. American Academy of Pediatrics Committee on Infectious Diseases Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286 [TBL] [Abstract][Full Text] [Related]
14. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). Cortese MM; Parashar UD; MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial. Iwata S; Nakata S; Ukae S; Koizumi Y; Morita Y; Kuroki H; Tanaka Y; Shizuya T; Schödel F; Brown ML; Lawrence J Hum Vaccin Immunother; 2013 Aug; 9(8):1626-33. PubMed ID: 23732903 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States. Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356 [TBL] [Abstract][Full Text] [Related]
17. Rotavirus Vaccination Can Be Performed Without Viral Dissemination in the Neonatal Intensive Care Unit. Hiramatsu H; Suzuki R; Nagatani A; Boda H; Miyata M; Hattori F; Miura H; Sugata K; Yamada S; Komoto S; Taniguchi K; Ihira M; Nishimura N; Ozaki T; Yoshikawa T J Infect Dis; 2018 Jan; 217(4):589-596. PubMed ID: 29165657 [TBL] [Abstract][Full Text] [Related]
18. Use of rotavirus vaccines in preterm babies on the neonatal unit. Kilich E; Sadarangani M Expert Rev Vaccines; 2016 Dec; 15(12):1463-1465. PubMed ID: 27454209 [No Abstract] [Full Text] [Related]
19. Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination. Hofstetter AM; Lacombe K; Klein EJ; Jones C; Strelitz B; Jacobson E; Ranade D; Ward ML; Mijatovic-Rustempasic S; Evans D; Wikswo M; Bowen MD; Parashar UD; Payne DC; Englund JA Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29212881 [TBL] [Abstract][Full Text] [Related]
20. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. ; Pediatrics; 2009 May; 123(5):1412-20. PubMed ID: 19332437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]